# Metabolic Effect of an Innovative Chitosan Formulation

> **NCT05188430** · NA · UNKNOWN · sponsor: **University of Bologna** · enrollment: 60 (estimated)

## Conditions studied

- Hypercholesterolemia
- Overweight and Obesity

## Interventions

- **DEVICE:** Medical Device (Kaptufat®)
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05188430
- **Lead sponsor:** University of Bologna
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03-01
- **Primary completion:** 2022-09-03
- **Final completion:** 2022-09-03
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2022-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05188430

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05188430, "Metabolic Effect of an Innovative Chitosan Formulation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05188430. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*